5PGY

CRYSTAL STRUCTURE OF 11BETA-HSD1 DOUBLE MUTANT (L262R, F278E) COMPLEXED WITH 2-[(5R,7S)-6-HYDROXY-2-PHENYLADAMANTAN-2-YL]-1-(3-HYDROXYAZETIDIN-1-YL)ETHAN-1-ONE (BMS-816336)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.07 Å
  • R-Value Free: 0.226 
  • R-Value Work: 0.186 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.

Ye, X.Y.Chen, S.Y.Wu, S.Yoon, D.S.Wang, H.Hong, Z.O'Connor, S.P.Li, J.Li, J.J.Kennedy, L.J.Walker, S.J.Nayeem, A.Sheriff, S.Camac, D.M.Ramamurthy, V.Morin, P.E.Zebo, R.Taylor, J.R.Morgan, N.N.Ponticiello, R.P.Harrity, T.Apedo, A.Golla, R.Seethala, R.Wang, M.Harper, T.W.Sleczka, B.G.He, B.Kirby, M.Leahy, D.K.Li, J.Hanson, R.L.Guo, Z.Li, Y.X.DiMarco, J.D.Scaringe, R.Maxwell, B.Moulin, F.Barrish, J.C.Gordon, D.A.Robl, J.A.

(2017) J. Med. Chem. 60: 4932-4948

  • DOI: 10.1021/acs.jmedchem.7b00211
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • BMS-816336 (6n-2), a hydroxy-substituted adamantyl acetamide, has been identified as a novel, potent inhibitor against human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme (IC50 3.0 nM) with >10000-fold selectivity over human 11β-hydroxyst ...

    BMS-816336 (6n-2), a hydroxy-substituted adamantyl acetamide, has been identified as a novel, potent inhibitor against human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme (IC50 3.0 nM) with >10000-fold selectivity over human 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). 6n-2 exhibits a robust acute pharmacodynamic effect in cynomolgus monkeys (ED50 0.12 mg/kg) and in DIO mice. It is orally bioavailable (%F ranges from 20 to 72% in preclinical species) and has a predicted pharmacokinetic profile of a high peak to trough ratio and short half-life in humans. This ADME profile met our selection criteria for once daily administration, targeting robust inhibition of 11β-HSD1 enzyme for the first 12 h period after dosing followed by an "inhibition holiday" so that the potential for hypothalamic-pituitary-adrenal (HPA) axis activation might be mitigated. 6n-2 was found to be well-tolerated in phase 1 clinical studies and represents a potential new treatment for type 2 diabetes, metabolic syndrome, and other human diseases modulated by glucocorticoid control.


    Organizational Affiliation

    Discovery Chemistry, ‡Pharmaceutical Candidate Optimization, §Computer-Assisted Drug Design, ∥Metabolic Diseases Biology, ⊥Lead Evaluation, #Process Chemistry, ∇Chemical Synthesis, ○Discovery Toxicology, Research and Development, Bristol-Myers Squibb , 350 Carter Road, Princeton, New Jersey 08540, United States.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Corticosteroid 11-beta-dehydrogenase isozyme 1
A, B, D, E
286Homo sapiensMutation(s): 2 
Gene Names: HSD11B1 (HSD11, HSD11L, SDR26C1)
EC: 1.1.1.146
Find proteins for P28845 (Homo sapiens)
Go to Gene View: HSD11B1
Go to UniProtKB:  P28845
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
NAP
Query on NAP

Download SDF File 
Download CCD File 
A, B, D, E
NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
C21 H28 N7 O17 P3
XJLXINKUBYWONI-NNYOXOHSSA-N
 Ligand Interaction
8KG
Query on 8KG

Download SDF File 
Download CCD File 
A, B, D, E
2-[(5R,7S)-6-HYDROXY-2-PHENYLADAMANTAN-2-YL]-1-(3-HYDROXYAZETIDIN-1-YL)ETHAN-1-ONE
C21 H27 N O3
OAAZMUGLOXGVNH-TUOVGCFYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.07 Å
  • R-Value Free: 0.226 
  • R-Value Work: 0.186 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 74.500α = 90.00
b = 92.300β = 90.00
c = 162.400γ = 90.00
Software Package:
Software NamePurpose
HKL-2000data collection
HKL-2000data reduction
BUSTERrefinement
HKL-2000data scaling
PDB_EXTRACTdata extraction
AMoREphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2017-02-06 
  • Released Date: 2017-11-01 
  • Deposition Author(s): Sheriff, S.

Revision History 

  • Version 1.0: 2017-11-01
    Type: Initial release
  • Version 1.1: 2018-02-21
    Type: Structure summary